M&T Bank Portfolio holdings
AUM
$29.1B
1-Year Return
16.72%
This Quarter Return
-13.22%
1 Year Return
+16.72%
3 Year Return
+64.24%
5 Year Return
+110.22%
10 Year Return
+221.4%
AUM
$21.2B
AUM Growth
-$1.4B
(-6.2%)
Cap. Flow
+$3.32B
Cap. Flow
% of AUM
15.62%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
1,643
New
183
Increased
1,126
Reduced
189
Closed
91
Top Buys
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$155M |
| 2 |
M&T Bank
MTB
|
+$152M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$129M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$127M |
| 5 |
Microsoft
MSFT
|
+$108M |
Top Sells
| 1 |
iShares MSCI Canada ETF
EWC
|
+$25.6M |
| 2 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$17.6M |
| 3 |
Restaurant Brands International
QSR
|
+$10.4M |
| 4 |
AT&T
T
|
+$10.2M |
| 5 |
VF Corp
VFC
|
+$7.57M |
Sector Composition
| 1 | Technology | 12.73% |
| 2 | Healthcare | 9.39% |
| 3 | Financials | 8.53% |
| 4 | Industrials | 5.36% |
| 5 | Consumer Staples | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWOU
1026
DELISTED
2U, Inc.
TWOU
| $482K | ﹤0.01% |
1,549
+780
| +101% | +$243K |
|
1027
F5
FFIV
$19.3B
| $479K | ﹤0.01% |
3,212
+314
| +11% | +$46.8K |
|
|
ABMD
1028
DELISTED
Abiomed Inc
ABMD
| $479K | ﹤0.01% |
2,021
+174
| +9% | +$41.2K |
|
1029
Charles River Laboratories
CRL
$7.7B
| $478K | ﹤0.01% |
2,684
+794
| +42% | +$141K |
|
1030
First Horizon
FHN
$11.6B
| $478K | ﹤0.01% |
24,468
+3,860
| +19% | +$75.4K |
|
1031
Heartland Express
HTLD
$661M
| $478K | ﹤0.01% |
34,651
+17,473
| +102% | +$241K |
|
1032
LegalZoom.com
LZ
$1.85B
| $477K | ﹤0.01% |
+43,697
| New | +$477K |
|
1033
Barclays
BCS
$72.6B
| $472K | ﹤0.01% |
73,924
+10,247
| +16% | +$65.4K |
|
1034
DXC Technology
DXC
$2.56B
| $470K | ﹤0.01% |
16,255
+399
| +3% | +$11.5K |
|
1035
Etsy
ETSY
$6.09B
| $470K | ﹤0.01% |
6,675
-598
| -8% | -$42.1K |
|
1036
C4 Therapeutics
CCCC
$194M
| $468K | ﹤0.01% |
61,994
+44,646
| +257% | +$337K |
|
1037
Instil Bio
TIL
$162M
| $468K | ﹤0.01% |
5,059
+4,269
| +540% | +$395K |
|
1038
SPDR Bloomberg Convertible Securities ETF
CWB
$4.49B
| $464K | ﹤0.01% |
11,005
+3,824
| +53% | +$161K |
|
1039
Pure Cycle
PCYO
$271M
| $464K | ﹤0.01% |
44,112
+26,841
| +155% | +$282K |
|
1040
CTS Corp
CTS
$1.24B
| $460K | ﹤0.01% |
13,528
-10,789
| -44% | -$367K |
|
1041
Acadia Healthcare
ACHC
$2B
| $459K | ﹤0.01% |
24,453
+14,676
| +150% | +$275K |
|
1042
BorgWarner
BWA
$9.5B
| $459K | ﹤0.01% |
28,853
+14,184
| +97% | +$226K |
|
1043
Coca-Cola Europacific Partners
CCEP
$40.7B
| $458K | ﹤0.01% |
+8,882
| New | +$458K |
|
1044
iShares MSCI Japan ETF
EWJ
$15.8B
| $458K | ﹤0.01% |
8,853
+5,432
| +159% | +$281K |
|
1045
Kiniksa Pharmaceuticals
KNSA
$2.7B
| $458K | ﹤0.01% |
47,296
| – | – |
|
1046
NOV
NOV
$4.91B
| $455K | ﹤0.01% |
28,406
+4,277
| +18% | +$68.5K |
|
1047
Zscaler
ZS
$44.5B
| $455K | ﹤0.01% |
3,090
+830
| +37% | +$122K |
|
1048
Relay Therapeutics
RLAY
$717M
| $454K | ﹤0.01% |
27,102
+16,586
| +158% | +$278K |
|
1049
Vanguard FTSE Europe ETF
VGK
$27.2B
| $453K | ﹤0.01% |
27,494
+19,607
| +249% | +$323K |
|
1050
Wintrust Financial
WTFC
$9.16B
| $452K | ﹤0.01% |
5,923
+11
| +0.2% | +$839 |
|